Package Leaflet: Information for the Patient
Duvyzat® 8.86 mg/ml oral suspension
givinostat
Select your language:
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.
